Document is current
Any future updates will be listed below
-
Authors
Pardo-Rodríguez, B.
Baraibar, A. M.
Manero-Roig, I.
Luzuriaga, J.
Salvador-Moya, J.
Polo, Y.
Basanta-Torres, R.
Unda, F.
Mato, S.
Ibarretxe, Gaskon https://orcid.org/0000-0002-4961-7402
Pineda, Jose Ramon https://orcid.org/0000-0002-0900-7466
-
Funding
Funding for this research was provided by:
Euskal Herriko Unibertsitatea (COLAB22/07, PhD fellowship PIFBUR21/05)
Eusko Jaurlaritza (IT1751-22, IT1473-22, ELKARTEK program MYOZET KK-2024/00111, PIBA_2023_1_0046, PhD fellowship PRE_2023_2_0112, PhD fellowship PRE_2023_2_0038, Bikaintek PostDoc grant 010-B1/2023, PostDoc grant POS_2019_1_0041)
Osasun Saila, Eusko Jaurlaritzako (“Strengthening strategic health research” program No. 2023333035, “Strengthening strategic health research” program No. 2023111031)
Ministerio de Ciencia e Innovación (PID2019-104766RB-C21, PID2023-152704OB-I00)
Instituto de Salud Carlos III (PI21/00629)
POLIMERBIO S.L. (contract 2023.0012)
ARSEP Foundation (ARSEP-1310)
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 8 January 2025
First Online: 23 January 2025
Declarations
:
: Human third molars were obtained from healthy donors of between 18 and 45 years of age and tooth samples were obtained by donation after written informed consent in compliance with the 14/2007 Spanish directive for Biomedical research. The study protocol was approved on date 03/02/2021 by the Ethics Committee of the University of the Basque Country UPV/EHU and the competent authority (Administración Foral de Bizkaia) regarding the use of human cells with CEISH M10/2020/172 and M10/2023/025 entitled “Matrices de anclaje nanoestructuradas basadas en grafeno y polímeros biodegradables para inducir la neurodiferenciación de células madre y regenerar el tejido nervioso”. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
